We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$36.5B
AUM Growth
+$3.93B
Cap. Flow
+$651M
Cap. Flow %
1.78%
Top 10 Hldgs %
7.68%
Holding
3,587
New
780
Increased
747
Reduced
671
Closed
866

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$223M
2
TJX icon
TJX Companies
TJX
+$191M
3
TDG icon
TransDigm Group
TDG
+$157M
4
IR icon
Ingersoll Rand
IR
+$155M
5
BP icon
BP
BP
+$152M

Sector Composition

Rank Sector Weight
1 Industrials 11.3%
2 Financials 10.99%
3 Technology 9.97%
4 Consumer Discretionary 9.35%
5 Healthcare 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALL icon
1926
PUT
Allstate
ALL
$64.7B
$339K ﹤0.01%
+2,500
New +$327K
NVTA
1927
DELISTED
Invitae Corporation
NVTA
$338K ﹤0.01%
181,742
+122,842
+209% +$300K
TLRY icon
1928
Tilray
TLRY
$640M
$330K ﹤0.01%
12,283
+7,141
+139% +$250K
NOV icon
1929
NOV
NOV
$7.45B
$330K ﹤0.01%
15,803
-2,839,175
-99% -$59.6M
GRAB icon
1930
Grab
GRAB
$15.1B
$330K ﹤0.01%
+102,351
New +$293K
OUT icon
1931
Outfront Media
OUT
$5.29B
$328K ﹤0.01%
20,101
-79,730
-80% -$1.35M
OPY icon
1932
Oppenheimer Holdings
OPY
$1.23B
$328K ﹤0.01%
+7,742
New +$285K
TECH icon
1933
Bio-Techne
TECH
$11.3B
$326K ﹤0.01%
+3,934
New +$312K
RMAX icon
1934
RE/MAX Holdings
RMAX
$263M
$325K ﹤0.01%
17,458
+191
+1% +$3.64K
CINC
1935
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$325K ﹤0.01%
+26,461
New +$631K
WDC icon
1936
PUT
Western Digital
WDC
$168B
$325K ﹤0.01%
13,627
WALDW icon
1937
Waldencast PLC Warrant
WALDW
$3.74M
$325K ﹤0.01%
523,669
+23,669
+5% +$16.1K
HLIT icon
1938
Harmonic Inc
HLIT
$1.42B
$323K ﹤0.01%
24,661
-84,166
-77% -$1.17M
ACRS icon
1939
Aclaris Therapeutics
ACRS
$860M
$323K ﹤0.01%
20,503
-85,644
-81% -$1.38M
PRO
1940
DELISTED
PROS Holdings
PRO
$321K ﹤0.01%
+13,250
New +$325K
TWI icon
1941
Titan International
TWI
$450M
$318K ﹤0.01%
+20,739
New +$296K
STRA icon
1942
Strategic Education
STRA
$1.81B
$317K ﹤0.01%
+4,051
New +$300K
UWMC icon
1943
UWM Holdings
UWMC
$2.42B
$316K ﹤0.01%
+95,319
New +$357K
ANSS
1944
PUT
DELISTED
Ansys
ANSS
$314K ﹤0.01%
1,300
+300
+30% +$69.9K
SP
1945
DELISTED
SP Plus Corporation
SP
$314K ﹤0.01%
+9,032
New +$312K
ODP
1946
DELISTED
ODP
ODP
$312K ﹤0.01%
+6,851
New +$293K
FVRR icon
1947
CALL
Fiverr
FVRR
$311M
$312K ﹤0.01%
10,700
-51,300
-83% -$1.61M
XPEL icon
1948
XPEL
XPEL
$1.35B
$310K ﹤0.01%
5,159
+492
+11% +$31.4K
CLX icon
1949
CALL
Clorox
CLX
$12.8B
$309K ﹤0.01%
+2,200
New +$312K
PDM
1950
Piedmont Realty Trust
PDM
$1.19B
$307K ﹤0.01%
33,495
-144,033
-81% -$1.42M

Similar funds

Balyasny Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Balyasny Asset Management held 3,587 positions worth $36.5B, up 12% from $32.6B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

Balyasny Asset Management's Q4 2022 filing shows 780 new, 747 increased, 671 reduced and 866 closed positions. Its largest new stake was TJX Companies: 2,589,145 shares worth $206M. The largest sale was ZENDESK INC, an estimated $300M.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

  • Balyasny Asset Management's largest Q4 2022 buy was TJX Companies: 2,589,145 shares worth $206M.
  • Balyasny Asset Management added most to Visa in Q4 2022, an estimated $223M increase.
  • Balyasny Asset Management's biggest Q4 2022 reduction was Union Pacific, cutting an estimated $252M.
  • Balyasny Asset Management fully exited ZENDESK INC in Q4 2022, selling an estimated $300M.
  • Balyasny Asset Management's ten largest holdings make up 7.7% of its $36.5B portfolio in Q4 2022.
  • Balyasny Asset Management opened 780 new positions and closed 866 in Q4 2022.
  • Balyasny Asset Management's portfolio value rose 12% quarter-over-quarter to $36.5B.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.